INFORMATION FOR VACCINE RECIPIENTS OR PARENTS/GUARDIANS

Patients, parents or guardians should be fully informed of the benefits and risks of immunization with Typhim (typhoid vi polysaccharide vaccine) Vi vaccine.

Prior to administration of Typhim (typhoid vi polysaccharide vaccine) Vi vaccine, patients, parents and guardians should be asked about the recent health status of the patient to be immunized.

Typhim (typhoid vi polysaccharide vaccine) Vi vaccine is indicated in persons traveling to endemic or epidemic areas. Current CDC advisories should be consulted with regard to specific locales.

Travelers should take all necessary precautions to avoid contact with or ingestion of contaminated food and water.

One dose of vaccine should be given at least 2 weeks prior to expected exposure.

Reimmunization consisting of a single-dose for US travelers every two years under conditions of repeated or continued exposure to the S typhi organism is recommended at this time.¹⁴

As part of the child's or adult's immunization record, the date, lot number and manufacturer of the vaccine administered should be recorded.¹⁷

REFERENCES

14. Recommendations of the Immunization Practices Advisory Committee (ACIP). Typhoid Immunization. MMWR 43: No. RR-14, 1994

17. CDC. Vaccine Adverse Event Reporting System - United

Last reviewed on RxList: 9/30/2008
This monograph has been modified to include the generic and brand name in many instances.